Blood markers for predicting kidney injury in acute pancreatitis
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at two simple blood markers (C-reactive protein and albumin) to see if they can help predict kidney damage in people with acute pancreatitis. If you join, you might help doctors find kidney problems earlier and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been diagnosed with acute pancreatitis (sudden swelling of the pancreas).
- You cannot be pregnant or breastfeeding.
- You must not have chronic kidney disease or kidney failure before this hospital stay.
- You must not have an active cancer, liver cirrhosis, active infection, or recent surgery.
- Your hospital stay must be longer than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific blood markers during an acute pancreatitis episode to better understand the condition. It may help improve treatment for future patients.
This study looks at whether simple blood test results can help doctors understand how severe your acute pancreatitis is and how well you might recover. By tracking these blood markers, doctors hope to better predict outcomes for future patients.
This study looks at whether a simple blood test (the ratio of platelets to albumin) can help predict if patients in the ICU will develop acute kidney injury (a sudden decrease in kidney function). If you are in the ICU, this test might help doctors detect kidney problems earlier and potentially improve care.
This study looks at whether certain blood tests can help predict if a patient in the intensive care unit (ICU) will develop acute kidney injury (a sudden loss of kidney function). It may help doctors detect kidney problems earlier and improve care for ICU patients.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
Hear when a new Acute Kidney Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.